about
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot studyXanthomas: clinical and pathophysiological relations.Pleiotropic effects of niacin: Current possibilities for its clinical use.The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids.Altered activities of antioxidant enzymes in patients with metabolic syndrome.Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study.N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress.Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.Fatty Acid Composition of Plasma Phosphatidylcholine Determines Body Fat Parameters in Subjects with Metabolic Syndrome-Related Traits.Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitusGlucose tolerance, insulin secretion, plasma lipid fatty acids, and the hypolipidemic effects of fish oilSeverity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in menEffects of dietary n-3 fatty acids on the composition of cholesteryl esters and triglycerides in plasma and liver perfusate of the ratPlasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters
P50
Q26799534-111CE785-D0A6-4862-A5A8-F27695ACBB71Q34584928-EB3AE7B7-8E17-4210-B11D-7F082281C28EQ38208169-11EDAE76-96E0-4ACD-A2E3-4D31256B3A7CQ38810790-478BEBB0-165F-4F52-AF8C-EDC7A6198557Q39162778-B187BCA3-4B9A-485E-AB48-095C7640EA43Q39787343-AF9783B6-E6D9-4AF1-AA6A-A202ABD6F335Q44231896-B3479021-4039-4D52-9EFD-B9FC4464CFADQ46157931-6D25150B-B479-413A-9DCD-9AD587DC76D2Q46743562-661AACAA-C111-4731-A68C-69BF2A4B4659Q46749686-B4CCF408-D043-4E9E-9E95-1E2A8B7F4F94Q51697993-D6212C03-9F93-49D6-A78A-F5CAB141957EQ53152255-9D6630AF-3C86-4720-93C1-C6CC946D6063Q57825188-CFCF3695-7F0B-47D1-9D1D-FCF6E367781FQ72882557-2086D388-ED4E-41BB-8AE1-BDA73B7D0ACDQ80694388-2148FEBD-C715-4CD7-A2BD-1DE69B2367C6Q80991384-1C033AC0-7842-40AF-BDD0-FB5087A26992Q87436709-D12AA569-5A89-4946-AA0C-4F8BDAEF5F26
P50
description
hulumtues
@sq
patolog, chirurg
@cs
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Miroslav Zeman
@ast
Miroslav Zeman
@cs
Miroslav Zeman
@en
Miroslav Zeman
@es
Miroslav Zeman
@nl
Miroslav Zeman
@sl
type
label
Miroslav Zeman
@ast
Miroslav Zeman
@cs
Miroslav Zeman
@en
Miroslav Zeman
@es
Miroslav Zeman
@nl
Miroslav Zeman
@sl
altLabel
Zeman M.
@en
prefLabel
Miroslav Zeman
@ast
Miroslav Zeman
@cs
Miroslav Zeman
@en
Miroslav Zeman
@es
Miroslav Zeman
@nl
Miroslav Zeman
@sl
P106
P214
P1053
J-5281-2016
P1153
56242451300
P19
P21
P214
P31
P3829
P496
0000-0001-5338-603X
P569
1942-01-30T00:00:00Z
P691
jn19990010040